St. Louis, MO—June 9, 2017— Acera Surgical Inc., a pioneer in regenerative medicine that utilizes its proprietary nanotechnology platform to create products for the major tissue defect markets, today announced that Dwayne Montgomery has joined Acera’s Board of Directors. Mr. […]Read More
Acera Surgical Inc., (“Acera”) a bioscience company located in St. Louis, MO received 510(k) clearance from the Food and Drug Administration (FDA) for its innovative wound care product, the Restrata™ Wound Matrix on April 26th. Restrata™ is a fully-synthetic electrospun wound […]Read More
ST.LOUIS – Acera Surgical, Inc., a Washington University startup co-founded by former WU student Dr. Matthew MacEwan, received 510(k) clearance from the Food and Drug Administration (FDA) for its first clinical product, the Cerafix® Dura Substitute. With the approval from […]Read More
ACERA Selected as One of the “Best University Startups 2016” by National Council of Entrepreneurial Tech Transfer
Acera Surgical has been selected as one of the “Best University Startups 2016” by National Council of Entrepreneurial Tech Transfer (NCET2).
NCET2 recognizes that Startup Officers are the backbone of any university’s research commercialization program. They work to support the world’s most […]
Acera Surgical has been selected to present at the 2016 Texas Life Science Venture Forum in Houston, Texas on May 26th, 2016.
Texas Life Science Forum is the premiere life science venture conference in the Southwest. The Forum is the most comprehensive showcase and […]